Loading clinical trials...

A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis | Clinical Trials | Clareo Health

Back to search

WITHDRAWNPHASE2

A Trial to Investigate the Effectiveness of Testosterone Treatment in Men With Multiple Sclerosis

NCT02317263•University of California, Los Angeles

View on ClinicalTrials.gov

Summary

This is a multicenter, prospective, placebo-controlled, double-blind randomized Phase II clinical trial assessing the effect of testosterone treatment vs. placebo treatment for 96 weeks duration on whole brain atrophy in men with MS.

Eligibility

Age

18 - 60 years

Sex

MALE

Healthy Volunteers

Key Dates

Primary Completion Date

January 1, 2099

Completion Date

January 1, 2099

Last Updated

August 4, 2016

Conditions

Multiple Sclerosis

Interventions

testosterone

DRUG

placebo gel

DRUG

A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis

NCT07225504

Secondary Progressive Multiple Sclerosis (SPMS)

View study

RECRUITINGNA

Intermittent Hypoxia in Persons With Multiple Sclerosis

NCT06276634

Multiple SclerosisMultiple Sclerosis-Relapsing-Remitting+1 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 4, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

RECRUITING